chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Two powerful migraine attacks in days immediately after taking the vaccine. Most importantly, after that, I've been left with a lingering issue in my brain/head. It's a sort of permanent headache, comparable to dizziness (though without imbalance/vertigo) that never goes away. Four months and counting. My neurologist attributes it to the vaccine. I'll still have occasional migraine attacks, but the main issue is this sort of second layer of headache that never goes away
Between 12/24/2020 and 2/8/2021, up to 81 individuals (staff and patients) may have received doses of the Moderna COVID-19 vaccine from vials that had been punctured >6 hours prior to administration.  At the time, staff were unaware of this stipulation.  On realizing the error, processes were shifted immediately and no further errors have occurred.  All potentially affected individuals were contacted with the exception of 2 individuals who were unable to be reached despite repeated calls and voicemails.  No adverse events were reported by anyone potentially affected.  This has been reported and is being handled by their vaccine safety team.
Information has been received from a registered nurse concerning a 56 year old male who on 07-NOV-2006 was vaccinated with Pneumovax 23, 0.5 ml, SQ.  Concomitant therapy included influenza virus vaccine (unspecified) which was received at the same visit but the vaccine was given at a different site.  It was reported that the patient developed a cellulitis "shortly after" his recent Pneumovax 23 and was treated with oral antibiotics.  The outcome of the cellulitis was not reported.  Cellulitis was considered to be an other important medical event.  Additional information has been requested.
CHIEF COMPLAINT Headache    HISTORY OF PRESENT ILLNESS:  Patient is a 42 y.o. female with medical comorbidities significant for hyperlipidemia (not on medication), migraine with aura (takes sumatriptan), depression who presents with chief complaint of left-sided pulsatile headache and dizziness of 1 day duration.    Yesterday she developed sudden onset tinnitus of the left ear and a pulsatile headache above and below the left ear. She states that these symptoms were very different than her migraine with aura, as it was not associated with photophobia, phonophobia, or nausea/vomiting. She took her sumatriptan after which her symptoms briefly improved but did not resolve. Also endorses associated dizziness which she describes as "feeling like you are on a boat and unsteady." Denies any recent fever, chills, or respiratory symptoms. She was concerned that she might be having a stroke, so she decided to present to the ED for further workup.    Workup in the ED significant for PCR-positive COVID-19. Electrolytes and complete blood count within normal limits. CT head non-contrast without acute intracranial abnormality. CTA head/neck significant for nonocclusive thrombus in the left sigmoid venous sinus, but patent intracranial nd cervical carotid and vertebral circulations.    She takes oral contraceptive pills and is a non-smoker. She has a longstanding history of migraine with aura for which she takes sumatriptan. Denies any known COVID-19 exposure or symtpoms. She did have a COVID-19 infection diagnosed in January of 2021, and received two doses of the Pfizer vaccine (March and April 2021).
Moderna COVID?19 Vaccine EUA Fever with Tmax of 103.0F at 21 hours - resolved after 2 days. Headache (occipital) - resolved after 2 days. Very mild vertigo and tinnitus - resolved after 2 days. Very sore arm and tender for a week. Tachycardia noted at 21 hours with resting heart rate of 110-125 for 1-2 days that normalized over the next 7 days. My resting heart rate is typically 60-65.
Full body aches, massive nonstop headache, stomache ache, and threw up yelloe bile.
Nausea, fatigue, muscle pain/tightness, diarrhea, milky ocular discharge, and dizziness. This was the 1st time to take the flu shot.
This spontaneous report as received from a nurse refers to a 12 year old patient of unknown gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 20-APR-2017, the patient was inadvertently vaccinated with a dose of PNEUMOVAX 23 injection (lot number: M043424, expiration date: 06-JUN-2018; exact dose and route of administration were not reported). No adverse effects were reported.  Additional information has been requested.
Paresthesia in my hands and legs; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), administration date 02Mar2021 (Lot number: EM9810) as dose 1, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PARAESTHESIA (non-serious) with onset Mar2021, outcome "unknown", described as "Paresthesia in my hands and legs". Additional information: The dose received by the patient was "0.3". The patient was scheduled to receive the second dose on 23Mar2021.  No follow-up attempts are possible. No further information is expected.
Felt chilling start around 4:30 PM as well as tingling in face and extremities. Continued with after work errands etc, within two hours was experiencing facial numbness and very bad frontal/facial headache as well as mild swelling of tongue. Took a Benadryl and went to bed. Woke up at 11:30 and called Nurse line as headache had increased and her hands and face were numb. Advised to go to ER. Went to ER at 1:30 AM and seen by Dr. Given a "pain pill" (unknown type) and a Valium as well as Sudafed and sent home. Slept all morning and at noon (10/1) headache is gone.
Vaccine was used that was labeled with a beyond use date of that day, but the vaccine should have been discarded that day. Label has "beyond use date" which implies ok to use on that date similar to other vaccines. NO adv rx of pt
Since Saturday Mar 28th, patient started developing rash/hives/hot rash/minor swollen mostly on his face, neck & around his ears, scratch his arms/legs.  Until today 4/14/15 the rash get more intense, widen and really bother him even at night.  His pediatrician try switch him to rice milk on 4/9/15, but patient still has series of rash, hive and itch on his face neck n limbs. Symptom developing everyday even eye lids will be puff when itch. Doctor prescribes Desonide cream, started apply on 4/7/15, but had to stop using next day.  Because it got him more red and burn.
PATIENT RECEIVED 1ST COVID VACCINE ON 8/7/21. AFTER RECEIVING THE VACCINE HE PASSED OUT AND LOST CONCIOUSNESS IN THE WAITING ROOM. THE FAMILY SAID THE PATIENT "ALWAYS DOES THIS" AFTER A VACCINE AND SAID IT USUALLY LASTS FOR 30 MINUTES. THE PATIENT WAS OBSERVED AND PULSE MONITORED. EMS WERE CALLED AS THE PATIENT REMAINED UNCONSCIOUS AND WAS STILL NOT AWARE AND RESPONSIVE WHEN EMS ARRIVED. THE FAMILY CAME BACK LATER THAT DAY AND SAID HE IS FINE NOW. THEY DID NOT SCHEDULE A 2ND VACCINE AND I MADE AWARE THEY COULD RESCHEDULE OR WALK IN IF DESIRED.
9 days after receiving vaccine, I suffered sudden hearing loss in my left ear. Prescribed Augmentin & Prednisone at Urgent Care on October 13, 2021. No improvement. Treated by ENT SPECIALIST, Dr.  (Ear, Nose & Throat) on 10/19/21. Was determined that I did NOT have an ear infection. Treatment included BINOCULAR MICROSCOPY, INJECTIONS OF DEXAMETHADONE 10 mg/10 Units, LEFT Transympanic Steroid Injection, Audiologic Testing with Tympanometry Order.
Muscle aches, stiff neck, and fatigue. Took ibuprofen to relieve pain.
This is a spontaneous report from a contactable pharmacist. An 83 year-old male patient received the first dose of PREVNAR 13 (lot R49357,  Expire Date: May2018, NDC 00005197102) intramuscular in the left upper arm on 07Jul2017 at 17:00 at 0.5 ml single for immunisation. No other vaccine was administered on same date. Medical history included ongoing gout. Concomitant medication included ongoing allopurinol for gout since 2015. The patient experienced left wrist swelling (the wrist was double in size) and it hurt a lot (pain) over the weekend on either 08Jul2017 or 09Jul2017. At the injection site there was nothing. The patient went to his doctor on 10Jul2017 and due to the events he was prescribed paracetamol, hydrocodone bitartrate (NORCO) for pain and methylprednisolone (MEDROL) dose pack as a steroid. The patient was not recovered. It was unknown if the patient was having a flare up of his gout or reaction to vaccine.
After patient received vaccine, extremely weak. Patient was unable to urinate, went to hospital, had no stones. Given antibiotic that was not helpful according to patient. Referred to a urologist; had to cath self 2 times a day. Patient reported being very weak, unable to drive or get up stairs. Events may be unrelated, but patient requested they be reported.
This is a spontaneous report from a contactable physician received via a sales representative who reported the same events for 3 different patients. This is the 2nd of 3 reports. A 13-year-old patient of an unspecified ethnicity and gender received TRUMENBA on an unspecified date at single dose for immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported.  The patient experienced chills, fever, headache, malaise, all on an unspecified date with unknown outcome. Sender's Comments: Linked Report(s): US-PFIZER INC-2016450423 Same reporter/drug/events, different patient; US-PFIZER INC-2016449736 Same reporter/drug/events, different patient.
increasing tenderness; redness; swelling; pain; It itched and the induration was about 15-20 mm; It itched and the induration was about 15-20 mm; This is a spontaneous report from a contactable nurse. A 65-year-old female patient received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13), via an unspecified route of administration on 12May2020 at a single dose for immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date in May2020, the patient experienced increasing tenderness, redness, swelling, pain for the first 6 days. It itched and the induration was about 15-20 mm on an unspecified date in May2020. The outcome of events was unknown.   No Follow-up attempts are needed. Information about lot/batch number cannot be obtained. No further information is expected.
Sore, achy arm. Tired, chills, body aches, possible fever.
First night: flu symptoms.  Next day: fatigue, drowsy, some flu symptoms.  That night: halucinatory dreams, woke up  and had difficulty with orientation - room spinning, difficulty walking came back to bed, bed spinning.  Got up later room spinning vertically - took several minutes to settle down.  This problem has gotten worse as the days go by.  This morning, dizziness persists longer than before, feeling of strong nausea, near vomiting, cannot walk in a straight line.  Fear of falling.   These are symptoms of vertigo I believe.  Should I go to a doctor?  Feeling that this will get worse.  Difficulty concentrating.  Quite an unsettling and scary experience.
Dizziness; Sleepy; Not feeling myself; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), SOMNOLENCE (Sleepy) and MALAISE (Not feeling myself) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Dizziness), SOMNOLENCE (Sleepy) and MALAISE (Not feeling myself). At the time of the report, DIZZINESS (Dizziness), SOMNOLENCE (Sleepy) and MALAISE (Not feeling myself) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment information was provided.  Patient did not want to take the 2nd dose because of the reaction she had after receiving the 1st dose   Most recent FOLLOW-UP information incorporated above includes: On 02-May-2021: Additional document attached and does not contain any new information
Arm pain started 12/15,  sudden onset of extreme vertigo 12/16 at ~1:30AM (patient doesn?t have a h/o vertigo) - patient ended up falling and hitting head, found self on floor bloody and still disorientated. Made it back to bed, cold sweat, body chills and aches followed. Patient unable to slowly move to sit or stand without ending up in the brink of falling unconscious. Happened several times over the course of several hours before patient was able to sit and walk without almost falling unconscious. Symptoms except for fatigue and minor headache dissipated by 6AM. Patient went to ED/ER provider to receive stitches for head laceration. Report written at 2:30PM on 12/16, patients course of illness continues
BODY ACHES; MIGRAINES; LOW GRADE FEVER; NAUSEA; FATIGUE; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient has other health problems. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced body aches, migraines, low grade fever, nausea, and fatigue. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) Low grade fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, migraines, low grade fever, nausea, and fatigue. This report was non-serious.
Day of vaccine pt told family felt cold/tired/h/a. Next day swollen/gray/ "not breathing" hosp with CHF - then went into A-fib.
Information has been received from a licensed practical nurse concerning a 9 year old white female with no known medical history or allergies who on 11-DEC-1997 was vaccinated with a first dose of Varivax. Concomitant vaccination administered that day included a dose of MMR. There was no illness at the time of vaccination. On 07-JUN-2006 the patient developed a chicken pox rash with vesicles. There were less than 50 lesions located on her chin and back. No laboratory diagnostic tests performed. There were no adverse events following prior vaccination. At the time of the report the patient was still recovering. Additional information has been requested.
After 2nd dose I will let you know as time continues but 24 hours later I have chronic pain all over my body, joints the worse, can't walk.; After 2nd dose I will let you know as time continues but 24 hours later I have chronic pain all over my body, joints the worse, can't walk. This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 57-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 14Nov2021 16:30 (Lot number: 32030BD) at the age of 56 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (dose number: 1, Product: COVID 19, Brand: Pfizer, lot number: 30125BA, dose Administration date: 24Oct2021, Administration time: 01:00 PM, Vaccine location: Right arm), administration date: 24Oct2021, when the patient was 56 years old, for Covid-19 Immunization, reaction(s): "Severe joint pain starting in elbow, moved to lower back, then hips, and knees by between date of 1st and 2nd dose.", "Severe joint pain starting in elbow, moved to lower back, then hips, and knees by between date of 1st and 2nd dose.", "Severe joint pain starting in elbow, moved to lower back, then hips, and knees by between date of 1st and 2nd dose.", "Severe joint pain starting in elbow, moved to lower back, then hips, and knees by between date of 1st and 2nd dose.". The following information was reported: GAIT INABILITY (non-serious), PAIN (non-serious) all with onset 15Nov2021, outcome "unknown" and all described as "After 2nd dose, she will let you know as time continues but 24 hours later she had chronic pain all over her body, joints the worse, can't walk.".  Additional Information: After 2nd dose, the patient will let you know as time continues but 24 hours later she had chronic pain all over her body, joints the worse, can't walk. The patient has not had Covid prior to vaccination and post-vaccination. No other vaccines were administered in four weeks. She has not received treatment for events, she did not test with the Covid test post-vaccination. She had no Covid vaccination prior.  No follow-up attempts are possible. No further information is expected.
No adverse effects reported; administered properly stored M-M-R II on 1/31/2019 two weeks after administration of properly stored V ARIV AX; This spontaneous report as received from a physician refers to a 16 year old patient of unknown gender. No information on patient's pertinent medical history, concomitant medications and drug reaction or allergies was provided.     On 15-JAN-2019, the patient was vaccinated with properly stored varicella virus vaccine live (oka/merck)(VARIVAX) (lot # reported as M023963 that is an invalid lot number for varicella virus vaccine live (oka/merck)(VARIVAX) , expiration date reported as 01-SEP-2019, dose and route of administration were not provided) for prophylaxis. On 31-JAN-2019 (also reported as two weeks after vaccination with  varicella virus vaccine live (oka/merck)(VARIVAX)) , the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (lot # reported as M025898 that is an invalid lot number for measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II), expiration date reported as 19-SEP-2019, dose and route of administration were not provided) for prophylaxis. Both vaccines were reconstituted with properly stored sterile diluent. No adverse effects reported.
Achy, tiredness, headache, chills, fever, nausea muscle aches. Bed rest and ADVIL 3 days.
Pt c/o  headache and fatigue since she got her 2nd COVID vaccine Pfizer on 4/22/21 .  Pt speech clear, comfortable. . Also denies emergency sx at this time. Advised pt to monitor her sx.  And  pt education given, pt assure understanding.  Notified pt if her sx not getting better or getting more worse call  back or consult with her MD, also if any emergency sx arises call 911 or go to nearest ED.
pt recv vax 28MAR90 & 17JUL96 lab eval found the pt to be non-immune for rubella w/a titer of 0.12;
Swelling of right arm, painful to touch, constant burning, red swell at injection site approximate size 2.5" by 1.5".
redness, swelling, rash on arm of injection. pain in arm up through shoulder and neck. patient went to hospital the morning after shot. patient stated she was given a couple shots and received an antibiotic. Called patient the evening after seeing the doctor and she said she was feeling better. She stated she wasn't sure if she was allergic or if there was an infection.
Information has been received from a physician's assistant concerning a 55 year old male with hypercholesterolemia who on 3/18/03 was vaccinated with a first dose of pneumococcal vaccine 23 polyvalent (lot # 644105/0820M). Concomitant medications included pravastatin sodium (Pravachol) and simvastatin. There were no concomitant medications reported. Four to six hours after vaccination on 03/18/2003, the patient developed left arm swelling, left arm redness, joint pain, a temperature of 101 degrees, and cellulitis. The reporter indicated that the patient was hospitalized on 3/19/03. It was noted that his white blood cell count and SED rate were elevated. The patient was treated with dexamethasone, unspecified IV antibiotics, and morphine in the hospital. The reporter indicated that the patient has started to recovered, and was released from the hospital 3/23/03. Unspecified medical attention was sought. Follow up information received from physician's assistant indicated that the patient developed swelling and pain in his left arm, left shoulder, ankles, knees, and neck. He was noted to have 4+ edema of his left arm and 1+ edema of his lower extremities. The patient was hospitalized on 3/19/03. His WBC level upon admission was 14,000. He was diagnosed with septicemia. He was treated with IV dexamethasone, unspecified IV antibiotics, and an IV morphine pump. During the hospitalization, the patient's white blood cell level was 17,900. It was reported that the patient was hospitalized for 4 days. As of 3/25/03, the patient was being treated daily in the office as an outpatient with IV ceftriaxone sodium (ROCEPHIN). The reporter noted that the patient was recovering and that he no longer required pain medication. Additional information has been requested. Additional information from a aphysician's assistant indicated that the patient was seen on 03/21/2003 and was noted to have severe cellulitis, erythema, edema of the entire left arm, neck swelling, and pain of all extremeties and joints. The reporter indicated that the patient's experience required an emergency room/doctor's visit, required a 5 day hospitalization, resulted in a persistent for significant disability/incapacity, and required medical/surgical intervention. It also noted that the patient is still recovering.  Reported on 06/03/2003: " Follow up information received from a physician's assistant indicated that the patient "completely recovered and has no associated symptoms".  No further information is expected.
She accidently got another dose of Shingrix; This non-serious case was reported by a consumer via call center representative and described the occurrence of extra dose administered in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (The patient received 2 doses of Shingrix 3 years ago) and Shingrix.   On 20-SEP-2023, the patient received the 3rd dose of Shingrix. On 20-SEP-2023, an unknown time after receiving Shingrix, the patient experienced extra dose administered (Verbatim: She accidently got another dose of Shingrix).  The outcome of the extra dose administered was unknown.   Additional Information: GSK Receipt Date: 20-SEP-2023 The patient self-reported this case. The patient received 2 doses of Shingrix 3 years ago. The patient accidently got another dose of Shingrix from the pharmacy today, which led to extra dose administered. The reporter did not consent to follow-up.